Home Healthcare Pharmaceuticals Nuclear Medicine Market

Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostics, Therapeutics), By Application (Cardiology, Therapeutic Applications, Neurology, Oncology, Thyroid, Lymphoma, Bone Metastasis, Endocrine Tumor, Pulmonary Scans, Urology, Other), By End Use (Hospitals, Diagnostic Centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: March 24, 2026 | Author: Debashree B | Format: | Report Code: SR641DR | Pages: 150
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Nuclear Medicine Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Diagnostics
      1. SPECT
        1. TC-99m
        2. TL-201
        3. GA-67
        4. I-123
        5. Others
      2. PET
        1. F-18
        2. SR-82/RB-82
        3. PYLARIFY (piflufolastat F 18)
        4. Illuccix (gallium Ga 68 gozetotide)
        5. Others
    2. Therapeutics
      1. Alpha Emitters
        1. RA-223
        2. Others
      2. Beta Emitters
        1. I-131
        2. Y-90
        3. SM-153
        4. Re-186
        5. Lu-177
        6. Others
      3. Brachytherapy
        1. Cesium-131
        2. Iodine-125
        3. Palladium-103
        4. Iridium-192
        5. Others
  2. Nuclear Medicine Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Cardiology
      1. SPECT
      2. PET
    2. Therapeutic Applications
    3. Neurology
    4. Oncology
    5. Thyroid
      1. SPECT
      2. Therapeutic Applications
    6. Lymphoma
    7. Bone Metastasis
      1. SPECT
      2. Therapeutic Applications
    8. Endocrine Tumor
    9. Pulmonary Scans
    10. Urology
    11. Other
  3. Nuclear Medicine Market, By End Use 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Diagnostic Centers
    3. Others
  4. Regional Nuclear Medicine Market
    1. North America
      1. North America Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      2. North America Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      3. North America Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
      4. U.S. Nuclear Medicine Market
        1. U.S. Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. U.S. Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. U.S. Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
      5. Canada Nuclear Medicine Market
        1. Canada Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. Canada Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. Canada Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
    2. Europe
      1. Europe Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      2. Europe Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      3. Europe Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
      4. U.K. Nuclear Medicine Market
        1. U.K. Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. U.K. Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. U.K. Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
      5. Germany Nuclear Medicine Market
        1. Germany Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. Germany Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. Germany Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
      6. France Nuclear Medicine Market
        1. France Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. France Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. France Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
      7. Spain Nuclear Medicine Market
        1. Spain Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. Spain Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. Spain Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
      8. Italy Nuclear Medicine Market
        1. Italy Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. Italy Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. Italy Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
      9. Russia Nuclear Medicine Market
        1. Russia Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. Russia Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. Russia Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
      10. Nordic Nuclear Medicine Market
        1. Nordic Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. Nordic Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. Nordic Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
      11. Benelux Nuclear Medicine Market
        1. Benelux Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. Benelux Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. Benelux Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
      12. Rest of Europe Nuclear Medicine Market
        1. Rest of Europe Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. Rest of Europe Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. Rest of Europe Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
    3. APAC
      1. APAC Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      2. APAC Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      3. APAC Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
      4. China Nuclear Medicine Market
        1. China Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. China Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. China Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
      5. Korea Nuclear Medicine Market
        1. Korea Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. Korea Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. Korea Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
      6. Japan Nuclear Medicine Market
        1. Japan Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. Japan Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. Japan Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
      7. India Nuclear Medicine Market
        1. India Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. India Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. India Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
      8. Australia Nuclear Medicine Market
        1. Australia Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. Australia Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. Australia Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
      9. Taiwan Nuclear Medicine Market
        1. Taiwan Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. Taiwan Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. Taiwan Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
      10. South East Asia Nuclear Medicine Market
        1. South East Asia Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. South East Asia Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. South East Asia Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
      11. Rest of Asia-Pacific Nuclear Medicine Market
        1. Rest of Asia-Pacific Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. Rest of Asia-Pacific Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. Rest of Asia-Pacific Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
    4. Middle East and Africa
      1. Middle East and Africa Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      2. Middle East and Africa Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      3. Middle East and Africa Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
      4. UAE Nuclear Medicine Market
        1. UAE Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. UAE Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. UAE Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
      5. Turkey Nuclear Medicine Market
        1. Turkey Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. Turkey Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. Turkey Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
      6. Saudi Arabia Nuclear Medicine Market
        1. Saudi Arabia Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. Saudi Arabia Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. Saudi Arabia Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
      7. South Africa Nuclear Medicine Market
        1. South Africa Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. South Africa Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. South Africa Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
      8. Egypt Nuclear Medicine Market
        1. Egypt Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. Egypt Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. Egypt Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
      9. Nigeria Nuclear Medicine Market
        1. Nigeria Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. Nigeria Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. Nigeria Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
      10. Rest of MEA Nuclear Medicine Market
        1. Rest of MEA Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. Rest of MEA Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. Rest of MEA Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
    5. LATAM
      1. LATAM Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      2. LATAM Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      3. LATAM Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
      4. Brazil Nuclear Medicine Market
        1. Brazil Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. Brazil Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. Brazil Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
      5. Mexico Nuclear Medicine Market
        1. Mexico Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. Mexico Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. Mexico Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
      6. Argentina Nuclear Medicine Market
        1. Argentina Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. Argentina Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. Argentina Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
      7. Chile Nuclear Medicine Market
        1. Chile Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. Chile Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. Chile Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
      8. Colombia Nuclear Medicine Market
        1. Colombia Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. Colombia Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. Colombia Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
      9. Rest of LATAM Nuclear Medicine Market
        1. Rest of LATAM Nuclear Medicine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Diagnostics
            1. SPECT
              1. TC-99m
              2. TL-201
              3. GA-67
              4. I-123
              5. Others
            2. PET
              1. F-18
              2. SR-82/RB-82
              3. PYLARIFY (piflufolastat F 18)
              4. Illuccix (gallium Ga 68 gozetotide)
              5. Others
          2. Therapeutics
            1. Alpha Emitters
              1. RA-223
              2. Others
            2. Beta Emitters
              1. I-131
              2. Y-90
              3. SM-153
              4. Re-186
              5. Lu-177
              6. Others
            3. Brachytherapy
              1. Cesium-131
              2. Iodine-125
              3. Palladium-103
              4. Iridium-192
              5. Others
        2. Rest of LATAM Nuclear Medicine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Cardiology
            1. SPECT
            2. PET
          2. Therapeutic Applications
          3. Neurology
          4. Oncology
          5. Thyroid
            1. SPECT
            2. Therapeutic Applications
          6. Lymphoma
          7. Bone Metastasis
            1. SPECT
            2. Therapeutic Applications
          8. Endocrine Tumor
          9. Pulmonary Scans
          10. Urology
          11. Other
        3. Rest of LATAM Nuclear Medicine Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Centers
          3. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.